Thrombocytopenia resident survival guide: Difference between revisions

Jump to navigation Jump to search
Line 64: Line 64:


==Do's==
==Do's==
*Bone marrow biopsy should be done for patients that are older than 60 years of age to rule out myelodysplastic syndrome or lymphoproliferative disorders.
* Order a peripheral blood smear in all patients with [[thrombocytopenia]] and check out the morphology of all blood cells lineages.  The [[peripheral blood smear]] is one of the most important tests to order in the evaluation of [[thrombocytopenia]].
*Treatment should be considered for patients with platelet counts less than 30,000 per microliter.
 
* Rule out [[leukemia]], manifested by [[blast]]s, and thrombotic microangiopathy, characterised by the presence of [[shistocytes]], in critically ill patients.
 
* Bone marrow biopsy should be done for patients that are older than 60 years of age to rule out myelodysplastic syndrome or lymphoproliferative disorders.
* Treatment should be considered for patients with platelet counts less than 30,000 per microliter.


==Dont's==
==Dont's==

Revision as of 14:25, 24 January 2014

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ogheneochuko Ajari, MB.BS, MS [2]

Introduction

Thrombocytopenia is the decreased concentration of platelets below 150,000 cells per microliter of blood.

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Management

Shown below is an algorithm depicting the initial approach to thrombocytopenia.[5]

 
 
 
Characterize the symptoms:
❑ Onset (acute, chronic, recurrent)
❑ Easy bruising
❑ Petechiae
❑ Rashes
❑ Melena
Fevers
Bleeding
Headaches
Abdominal pain
❑ Visual disturbances
Weight loss
❑ Night sweats
❑ Bone pain
Obtain a detailed history:
❑ Recent medications
❑ Pregnancy
❑ Family history
❑ Malignancy
❑ Recent infection
❑ Recent vaccinations
❑ Recent travels
❑ Recent transfusions
❑ Chronic alcohol use
❑ Recent hospitalization
❑ Recent organ transplantation
❑ Recent valve replacement surgery
❑ Dietary habits
❑ Sexual history
❑ Ingestion of quinine containing beverages
 
 
 
 
 
 
 
 
 
 
 
 
Examine the patient:
❑ Bleeding location
❑ Bleeding severity
Hepatomegaly
Splenomegaly
❑ Mucocutaneous bleeding
❑ Skeletal abnormalities
❑ Joint or soft tissue bleeding
Rash
❑ Generalized lymphadenopathy
❑ Skin necrosis
❑ Neurologic exam
 
 
 
 
 
 
 
 
 
 
 
 
Order tests:
Peripheral blood smear
CBC and differential
Reticulocyte count
LDH
LFT
❑ Renal function test
❑ Clotting screen
PT
aPTT
Fibrinogen
Haptoglobin
D-dimer
❑ Request a hematology consult
 
 
 
 
 
 
 
 
 
 
 
 
❑ Order additional tests based on the results of the CBC-D and peripheral blood smear
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Possible Pseudothrombocytopenia
❑ Clumped platelets
 
 
 
True thrombocytopenia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
❑ Order platelet count on heparinized blood specimen
 
Isolated thrombocytopenia
 
Thrombocytopenia with abnormalities in other blood lineages
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider:
ITP
TTP
DIC
 
Guide your next step by specific findings
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Look for:
❑ Shistocytes ❑ Spherocytes
❑ Dacrocytes ❑ Blasts
Giant platelets ❑ Granulations
❑ Hypersegmented neutrophils
❑ Macrocytosis ❑ Lymphocytosis
❑ Neutropenia
 


Treatment of Thrombocytopenia

The treatment of thrombocytopenia is specific to the underlying cause of thrombocytopenia.

Do's

  • Rule out leukemia, manifested by blasts, and thrombotic microangiopathy, characterised by the presence of shistocytes, in critically ill patients.
  • Bone marrow biopsy should be done for patients that are older than 60 years of age to rule out myelodysplastic syndrome or lymphoproliferative disorders.
  • Treatment should be considered for patients with platelet counts less than 30,000 per microliter.

Dont's

  • Don't initiate cancer chemotherapy or antiviral therapy in the presence of thrombocytopenia.[5]
  • Don't start the treatment for platelet counts greater than 50,000 per microliter unless the patient is actively bleeding.
  • Don't give warfarin monotherapy to an acutely bleeding patient because it may induce thrombosis.

References

  1. 1.0 1.1 1.2 1.3 Greenberg EM, Kaled ES (2013). "Thrombocytopenia". Crit Care Nurs Clin North Am. 25 (4): 427–34, v. doi:10.1016/j.ccell.2013.08.003. PMID 24267279.
  2. Farid J, Gul N, Qureshi WU, Idris M (2012). "Clinical presentations in immune thrombocytopenic purpura". J Ayub Med Coll Abbottabad. 24 (2): 39–40. PMID 24397048.
  3. Nisha S, Amita D, Uma S, Tripathi AK, Pushplata S (2012). "Prevalence and characterization of thrombocytopenia in pregnancy in Indian women". Indian J Hematol Blood Transfus. 28 (2): 77–81. doi:10.1007/s12288-011-0107-x. PMC 3332269. PMID 23730013.
  4. Abdel Karim N, Haider S, Siegrist C, Ahmad N, Zarzour A, Ying J; et al. (2013). "Approach to management of thrombotic thrombocytopenic purpura at university of cincinnati". Adv Hematol. 2013: 195746. doi:10.1155/2013/195746. PMC 3876823. PMID 24396345.
  5. 5.0 5.1 Stasi R (2012). "How to approach thrombocytopenia". Hematology Am Soc Hematol Educ Program. 2012: 191–7. doi:10.1182/asheducation-2012.1.191. PMID 23233580.

Template:WH Template:WS